Literature DB >> 30787661

Are IL1B, IL6 and IL6R Gene Variants Associated with Anterior Cruciate Ligament Rupture Susceptibility?

Ewelina Lulińska-Kuklik1, Ewelina Maculewicz2, Waldemar Moska1, Krzysztof Ficek3, Mariusz Kaczmarczyk1, Monika Michałowska-Sawczyn4, Kinga Humińska-Lisowska4, Maciej Buryta4, Jakub Chycki5, Pawel Cięszczyk5, Piotr Żmijewski6, Agata Rzeszutko7, Marek Sawczuk1, Petr Stastny8, Miroslav Petr8, Agnieszka Maciejewska-Skrendo4.   

Abstract

Cytokines, such as interleukins, are crucial in regulating critical cell signaling pathways as well as being major contributors to inflammatory response and are upregulated during ligament and tendon injuries. The genes encoding key interleukins, such as IL1B and IL6 as well as interleukin receptor IL6R, were chosen as candidate genes for association with soft tissue injuries. The aim of the case-control study was to verify the hypothesis that sequence variants rs1143627, rs16944, rs1800795, rs2228145 in the IL1B, IL6 and IL6R genes are associated with ACL rupture susceptibility in a Polish population. Among four analyzed SNPs, the rs1800795 IL6 gene polymorphism was found to be the only one significantly associated with ACL rupture (p = 0.010, p = 0.022, p = 0.004 for codominant, recessive and overdominant models, respectively; odds ratio = 1.74, 95% CI 1.08-2.81, sex adjusted p = 0.032 for recessive model). With reference to the other analyzed polymorphisms, we failed to show significant differences in the genotype and allele frequencies for IL6R rs2228145as well as IL1B rs16944 and rs1143627 (analyzed alone or in haplotype combination) between the ACL rupture group and the healthy control group among Polish participants. Due to the nature of case-control studies, the results of this study need to be confirmed in independent studies with larger sample sizes.

Entities:  

Keywords:  ACL rupture; IL1B; IL6; IL6R; Soft tissue injuries

Mesh:

Substances:

Year:  2019        PMID: 30787661      PMCID: PMC6370956     

Source DB:  PubMed          Journal:  J Sports Sci Med        ISSN: 1303-2968            Impact factor:   2.988


  43 in total

1.  The COL5A1 gene and Achilles tendon pathology.

Authors:  G G Mokone; M P Schwellnus; T D Noakes; M Collins
Journal:  Scand J Med Sci Sports       Date:  2006-02       Impact factor: 4.221

2.  The association between the COL12A1 gene and anterior cruciate ligament ruptures.

Authors:  Michael Posthumus; Alison V September; Dion O'Cuinneagain; Willem van der Merwe; Martin P Schwellnus; Malcolm Collins
Journal:  Br J Sports Med       Date:  2009-05-13       Impact factor: 13.800

3.  Cyclic mechanical stretching enhances secretion of Interleukin 6 in human tendon fibroblasts.

Authors:  M Skutek; M van Griensven; J Zeichen; N Brauer; U Bosch
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2001-09       Impact factor: 4.342

Review 4.  Interleukin-1: a gene expression system regulated at multiple levels.

Authors:  P E Auron; A C Webb
Journal:  Eur Cytokine Netw       Date:  1994 Nov-Dec       Impact factor: 2.737

5.  Interleukin-3 stimulates matrix metalloproteinase 12 production from macrophages promoting thoracic aortic aneurysm/dissection.

Authors:  Chang Liu; Congcong Zhang; Lixin Jia; Boya Chen; Luxin Liu; Jie Sun; Wenmei Zhang; Bin You; Yulin Li; Ping Li; Jie Du
Journal:  Clin Sci (Lond)       Date:  2018-03-26       Impact factor: 6.124

6.  Matrix metalloproteinase genes on chromosome 11q22 and the risk of anterior cruciate ligament (ACL) rupture.

Authors:  M Posthumus; M Collins; L van der Merwe; D O'Cuinneagain; W van der Merwe; W J Ribbans; M P Schwellnus; S M Raleigh
Journal:  Scand J Med Sci Sports       Date:  2011-03-16       Impact factor: 4.221

7.  A pathway-based approach investigating the genes encoding interleukin-1β, interleukin-6 and the interleukin-1 receptor antagonist provides new insight into the genetic susceptibility of Achilles tendinopathy.

Authors:  Alison V September; Erica-Mari Nell; Kevin O'Connell; Jill Cook; Christopher J Handley; Lize van der Merwe; Martin Schwellnus; Malcolm Collins
Journal:  Br J Sports Med       Date:  2011-05-10       Impact factor: 13.800

8.  A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women.

Authors:  S L Ferrari; P Garnero; S Emond; H Montgomery; S E Humphries; S L Greenspan
Journal:  Arthritis Rheum       Date:  2001-01

9.  Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced.

Authors:  J C Galicia; H Tai; Y Komatsu; Y Shimada; K Akazawa; H Yoshie
Journal:  Genes Immun       Date:  2004-09       Impact factor: 2.676

10.  Genetic susceptibility of intervertebral disc degeneration among young Finnish adults.

Authors:  Anthi Kelempisioti; Pasi J Eskola; Annaleena Okuloff; Ulla Karjalainen; Jani Takatalo; Iita Daavittila; Jaakko Niinimäki; Roberto B Sequeiros; Osmo Tervonen; Svetlana Solovieva; Patrick Y P Kao; You-Qiang Song; Kenneth M C Cheung; Danny Chan; Leena Ala-Kokko; Marjo-Riitta Järvelin; Jaro Karppinen; Minna Männikkö
Journal:  BMC Med Genet       Date:  2011-11-22       Impact factor: 2.103

View more
  3 in total

1.  Shear strain and inflammation-induced fixed charge density loss in the knee joint cartilage following ACL injury and reconstruction: A computational study.

Authors:  Gustavo A Orozco; Atte S A Eskelinen; Joonas P Kosonen; Matthew S Tanaka; Mingrui Yang; Thomas M Link; Benjamin Ma; Xiaojuan Li; Alan J Grodzinsky; Rami K Korhonen; Petri Tanska
Journal:  J Orthop Res       Date:  2021-10-01       Impact factor: 3.102

Review 2.  Tendon and Ligament Genetics: How Do They Contribute to Disease and Injury? A Narrative Review.

Authors:  William J Ribbans; Alison V September; Malcolm Collins
Journal:  Life (Basel)       Date:  2022-04-29

3.  Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries.

Authors:  Lutfiye Karcioglu Batur; Nezih Hekim
Journal:  J Med Virol       Date:  2021-06-10       Impact factor: 20.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.